Cheiradone: a vascular endothelial cell growth factor receptor antagonist

BACKGROUND: Angiogenesis, the growth of new blood vessels from the pre-existing vasculature is associated with physiological (for example wound healing) and pathological conditions (tumour development). Vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2) and epidermal growt...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Sajjad, Slevin, Mark, Mesaik, Mohammad A, Choudhary, Mohammad I, Elosta, Abdul H, Matou, Sabine, Ahmed, Nessar, West, David, Gaffney, John
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248182/
https://www.ncbi.nlm.nih.gov/pubmed/18230134
http://dx.doi.org/10.1186/1471-2121-9-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248182/
https://www.ncbi.nlm.nih.gov/pubmed/18230134
http://dx.doi.org/10.1186/1471-2121-9-7

Ejemplares similares